Release Date: 27/08/09 15:26 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 171.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%